As the UPC continues to take shape through early rulings, procedural clarifications, and appeals, legal teams across Europe are watching closely to understand how this new venue is redefining enforcement strategy. This session offers a practical review of the key decisions to date, considers procedural and jurisdictional trends, and examines the strategic calculus of litigating in the UPC versus national courts.
• Review recent UPC case law and appeals to understand emerging judicial approaches and procedural norms:
- Edwards Lifesciences v Meril (2025)
- Mul-T-Lock v IMC Créations (2025)
- Abbott Diabetes Care v Sibio Technology (2025)
• Examine strategic decision-making: when and why companies are choosing the UPC over national courts. Compare early UPC developments to UK patent litigation to identify points of convergence and divergence.